🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tanyel Kiziltepe

University of Notre Dame

ORCID: 0000-0002-9491-8546

Also affiliated with Marmara University

MedicineMaterials ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy”.

Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.04.010
N/A
0DataRank · unranked
75 citations

Jae-Ho Shin, Junmin Wu, David T. Omstead, Tanyel Kiziltepe, Laurie E. Littlepage +2 more

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

Journal of Hematology & Oncology(2020)10.1186/s13045-020-00965-4
N/A
0DataRank · unranked
38 citations

Franklin Mejia, Jenna Sjoerdsma, Baksun Kim, Jae-Ho Shin, Sabrina Khan +5 more

Data from The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo

(2023)10.1158/1078-0432.c.6517504
N/A
0DataRank · unranked
0 citations

Teru Hideshima, Mariateresa Fulciniti, Robert J. Lutz, Hiroshi Yasui, Yutaka Okawa +16 more

Data from The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo

(2023)10.1158/1078-0432.c.6517504.v1
N/A
0DataRank · unranked
0 citations

Teru Hideshima, Mariateresa Fulciniti, Robert J. Lutz, Hiroshi Yasui, Yutaka Okawa +16 more

Combination non-targeted and sGRP78-targeted nanoparticle drug delivery outperforms either component to treat metastatic ovarian cancer

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.09.014
N/A
0DataRank · unranked
7 citations

Emily K. Bromley, Jae-Ho Shin, Tyvette S. Hilliard, Yueying Liu, Caitlin Horgan +7 more